Featured Stories

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Actos Makers Continue to Face Bladder Cancer Claims

Lawsuits continue to be filed over Actos, a type 2 diabetes drug developed by Takeda and Eli Lilly. Plaintiffs in the litigation allege that Actos contributed to bladder cancer. Drug makers are accused of failing to disclose this risk to patients and their physicians. Court records indicate that a new Actos lawsuit was filed in June 2016.
The lawsuit, like others consolidated in the Actos multidistrict litigation (MDL) alleges that the plaintiff’s bladder cancer was a result of taking Actos. He alleges that the drug’s side effects ultimately led to economic damage due to medical bills and lost wages, mental and physical pain. The plaintiff took Actos for six years, according to the complaint.

At the time the June lawsuit was filed, the MDL contained over 4,500 lawsuits alleging Actos led to bladder cancer. MDLs are established when there are lawsuits with the same allegations. In order to make legal proceedings move quickly and efficiently, these lawsuits are centralized to one court before one judge. This consolidation helps eliminate duplicate discovery and conserves resources. In the Actos MDL, plaintiffs similarly allege that the manufacturers hid data linking Actos to bladder cancer. Continue reading

Posted in Legal News |

Increased Dementia Risk for Prostate Cancer Patients Undergoing ADT

A study published in JAMA Oncology stated that androgen deprivation therapy (ADT), a standard treatment for men with prostate cancer, may raise the risk of dementia. The use of ADT has increased dramatically in the last few decades with as many as 500,000 men currently receiving ADT in the United States.

“ADT has a demonstrated survival benefit in some patients with prostate cancer. However, it also has been linked to several adverse health effects”, wrote study authors led by Dr. Kevin T. Nead of Stanford University School of Medicine in California. “A growing body of evidence supports a link between ADT and cognitive dysfunction, including Alzheimer disease.” Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

California Tour Bus Crash Leaves 13 Dead, 31 Injured

Thirteen people were killed and 31 others were injured early Sunday morning, October 23, when the USA Holiday tour bus carrying them back from a casino near the Salton Sea crashed into a big rig truck near Palm Springs.

The passengers, many of whom were sleeping, had spent the night at the casino and were on the way back to Los Angeles when the crash occurred about 5:17 a.m., the Los Angeles Times reports. The bus slammed into the back of the truck’s trailer, crushing the front third of the bus. Most of those who died appeared to have been sitting toward the front of the bus.  Continue reading

Posted in Accident, Bus Accident | Tagged , , , , |

Court Rejects J&J Bid to Toss Talcum Powder Trial

A talcum powder lawsuit is currently on trial in St. Louis, Missouri. The plaintiff in the lawsuit is a 63-year-old California woman who suffers from stage 4 ovarian cancer. She alleges that using talcum powder for feminine hygiene for 44 years has contributed to her cancer, and accuses J&J of failing to warn consumers.

J&J has attempted to have the trial postponed and dismissed. The company suffered significant losses earlier this year, when juries awarded verdicts of $72 million and $55 million to talcum powder plaintiffs. Court document show that J&J tried to postpone the trial, but the judge overseeing the litigation moved the case towards resolution. A week before the trial began, J&J tried to postpone the trial again by trying to move the case to federal court. This motion was also denied. Continue reading

Posted in Defective Products, Health Concerns, Toxic Substances | Tagged , , , , , , |

HeartWare International Heart Pump Subject to FDA Class 1 Recall

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has classified two global voluntary recalls of HeartWare International’s HeartWare Ventricular Assist Device (HVAD) as Class 1 recalls.

A class 1 recall is the FDA’s most serious recall category, reserved for situations where there is a reasonable risk of serious adverse health consequences or death.

The HVAD helps deliver blood from the heart to the rest of the body. A ventricular assist device is used in patients who are at risk of death from end-stage left ventricular heart failure and who are waiting for a heart transplant. The HVAD system includes a pump that is implanted in the space around the heart (pericardium) and a controller to regulate the speed and function of the pump.


Continue reading

Posted in Defective Medical Devices, Product Recalls, Recalled Medical Devices | Tagged , , , , |

Lunchables Recalled Due to Undeclared Allergens, Misbranding

Kraft Heinz is recalling its ready-to-eat “Lunchables Ham and American Cracker Stackers because it is misbranded and contains undeclared allergens, including wheat and soy. These ingredients, which can cause a life-threatening allergic reaction in some individuals, were not listed on the product label. According to an Oct. 9 recall alert posted on the U.S. Department of Agriculture website, the recall affects 959 pounds of packaged lunch products.

The recalled Lunchables were produced on Sept. 21, 2016. The products have a “USE BY” date of 25 DEC 2016 and production times ranging from 9:13 to 10:00 stamped on the side of the container, the alert states. Inside the USDA mark of inspection, consumers can locate the establishment number. Products affected by the recall have establishment number “EST. 537K”. The Lunchables were distributed to Utah and California. Continue reading

Posted in Health Concerns, Product Recalls, Recalled Food Products | Tagged , , , , |

Nestlé Drumstick Ice Cream Cones Recalled

A voluntary recall has been issued for Nestlé Drumstick Club 16 count Variety Pack and 24 count Vanilla Pack (with cones marked for easy individual sale). Nestlé USA recalled the product because contact surfaces of equipment tested positive for Listeria monocytogenes. “The products impacted by the voluntary recall were put into distribution inadvertently. No illnesses have been reported to date; the company is initiating this recall as a precautionary action to avoid any potential for consumer illness.” according to an Oct. 7 recall alert posted on the U.S. Food and Drug Administration (FDA) website.

The drumstick ice cream cones themselves did not test positive for Listeria. The recall affects 4.6 fl. oz cones. According to the announcement, the product was manufactured in Bakersfield, California and distributed nationwide. Continue reading

Posted in Food Poisoning, Listeria, Product Recalls, Recalled Food Products | Tagged , , , |

New Jersey Students Injured in School Bus Collision

A school bus accident left dozens of New Jersey high school students injured in New City, New York. State police say one school bus rear-ended another while exiting the Palisades Interstate Parkway at Exit 11. Fortunately, there were no major injuries. The school buses were carrying students who attend Northern Valley Regional High School in Demarest, New Jersey.

According to Associated Press, the accident occurred on October 17th just after 2 p.m. All injuries were considered minor, and 40 to 60 students were taken to the hospital for bumps and bruises. Continue reading

Posted in Accident, Bus Accident | Tagged , , , , |

Deep Brain Stimulation Rechargers May Fail to Charge, Medtronic Warns

In an October 2016 “Urgent Field Safety Notice”, Medtronic warned that some rechargers for its deep brain stimulation devices may be prone to an “error state” and fail to charge. According to the letter, some of its Model 37751 rechargers may become unresponsive and fail to recharge the neurostimulator until they are reset. The company has received reports of the chargers malfunctioning, where they bleep every five seconds while displaying a blank screen.

According to the letter, the “error state” occurs in 2 percent of rechargers manufactured after November 2014 and 0.2 percent of rechargers manufactured before that date. The serial numbers on rechargers manufactured November 2014 and later begin with “NKA4” or “NKU4”. Continue reading

Posted in Defective Medical Devices | Tagged , , , , |

Zofran Blamed as Cause for Cleft Palate in New Lawsuit

On October 3, 2016, a mother claimed that the active ingredient in the anti-nausea drug Zofran’s caused her son to develop cleft palate and cleft lip in the womb. The woman, from Oneida, New York, filed her case in the U.S. District Court of Massachusetts, where more than 280 additional Zofran lawsuits are currently consolidated.

In 2012, researchers at Harvard and Boston University discovered that women prescribed Zofran for nausea during pregnancy were more than twice as likely to deliver children with a cleft palate. Zofran’s warning label, however, does not mention a potential increased risk for cleft palate. Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , |

© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.